ID: ALA3736333

Max Phase: Preclinical

Molecular Formula: C10H20ClNO3

Molecular Weight: 201.27

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)CN[C@@H]1C=C[C@H](O)[C@H](O)[C@H]1O.Cl

Standard InChI:  InChI=1S/C10H19NO3.ClH/c1-6(2)5-11-7-3-4-8(12)10(14)9(7)13;/h3-4,6-14H,5H2,1-2H3;1H/t7-,8+,9+,10+;/m1./s1

Standard InChI Key:  IZLSZCKSWMSHHR-MRUBQFBLSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 201.27

Molecular Weight (Monoisotopic): 201.1365

AlogP: -0.75

#Rotatable Bonds: 3

Polar Surface Area: 72.72

Molecular Species: BASE

HBA: 4

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 12.89

CX Basic pKa: 8.87

CX LogP: -0.42

CX LogD: -1.90

Aromatic Rings: 0

Heavy Atoms: 14

QED Weighted: 0.45

Np Likeness Score: 1.68

References

1. Kuno S, Higaki K, Takahashi A, Nanba E, Ogawa S.  (2015)  Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives,  6  (2): [10.1039/C4MD00270A]

Source

Source(1):

• Scientific Literature